Scientific Advisory Board

The Scientific Advisory Board (SAB) supports the NCT strategically on all crucial matters across locations. It advises the management boards, the Joint Steering Committee, and the NCT Directorates of Heidelberg and Dresden on all scientific and clinical matters as well as on strategic planning.

It is composed of nationally as well as internationally renowned clinicians and scientists from institutions which either combine clinical and scientific research, or which are purely research-oriented.

Members of the Scientific Advisory Board

Prof. Raymond DuBois (Chair)
Medical University of South Carolina (MUSC), USA

Prof. Marc Besselink
Amsterdam UMC (University Medical Centers), The Netherlands

Prof. Robert Bristow
Manchester Cancer Research Centre, the University of Manchester, UK

Prof. Ruggero de Maria
Alleanza Contro il Cancro (ACC), Italy

Prof. David Gonzalez de Castro
Queen’s University, Belfast, UK

Prof. Michelle Le Beau
The University of Chicago Comprehensive Cancer Center (UCCCC), the University of Chicago, USA

Prof. Elaine Mardis
Nationwide Children’s Hospital, Institute for Genomic Medicine, Ohio, USA

Prof. Cornelis Melief
ISA Pharmaceuticals, Niederlande

Prof. Radhe Mohan
MD Anderson Cancer Center, the University of Texas, USA

Prof. Michael Molls
Technische Universität München, TUM ForTe, Germany

Prof. Raphael Pollock
The Ohio State University Comprehensive Cancer Center, Columbus, USA

Prof. Ulrik Ringborg
Cancer Center Karolinska, Karolinska University Hospital, Sweden

Prof. Mihaela van der Schaar
University of Cambridge, UK (United Kingdom)

Prof. Paresh Vyas
MRC Weatherall Institute of Molecular Medicine, University of Oxford, UK

Prof. Laurence Zitvogel
Gustave Roussy Cancer Center, France